Back to top

Image: Bigstock

Will ProQR Therapeutics Continue to Surge Higher?

Read MoreHide Full Article

As of late, it has definitely been a great time to be an investor ProQR Therapeutics N.V. (PRQR - Free Report) .The stock has moved higher by 5.1% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.

We certainly think that this might be the case, particularly if you consider PRQR’s recent earnings estimate revision activity. From this look, the company’s future is quite favorable; asPRQR has earned itself a Zacks Rank #1 (Strong Buy), meaning that its recent run may continue for a bit longer, and that this isn’t the top for the in-focus company. You can see the complete list of today’s Zacks #1 Rank stocks here.

Wall Street’s Next Amazon

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.

Click for details >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


ProQR Therapeutics N.V. (PRQR) - free report >>

Published in